This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Ivkov, R. Articles by DeNardo, G. L. Search for Related Content PubMed PubMed Citation Articles by Ivkov, R. Articles by DeNardo, G. L.

Application of High Amplitude Alternating Magnetic Fields for Heat Induction of Nanoparticles Localized in Cancer

Authors' Affiliations: ¹ Triton BioSystems, Inc., Chelmsford, Massachusetts; ² Radiodiagnosis and Therapy, Molecular Cancer Institute, University of California, Davis, Sacramento, California; and ³ Centre for Induction Technology, Inc., Auburn Hills, Michigan

Requests for reprints: Robert Ivkov, Triton BioSystems, Inc., 200 Turnpike Road, Chelmsford, MA 01824. Phone: 978-856-4154; Fax: 978-250-4533; E-mail: rivkov{at}tritonbiosystems.com.

Objective: Magnetic nanoparticles conjugated to a monoclonal antibody can be i.v. injected to target cancer tissue and will rapidly heat when activated by an external alternating magnetic field (AMF). The result is necrosis of the microenvironment provided the concentration of particles and AMF amplitude are sufficient. High-amplitude AMF causes nonspecific heating in tissues through induced eddy currents, which must be minimized. In this study, application of high-amplitude, confined, pulsed AMF to a mouse model is explored with the goal to provide data for a concomitant efficacy study of heating i.v. injected magnetic nanoparticles.

Methods: Thirty-seven female BALB/c athymic nude mice (5-8 weeks) were exposed to an AMF with frequency of 153 kHz, and amplitude (400-1,300 Oe), duration (1-20 minutes), duty (15-100%), and pulse ON time (2-1,200 seconds). Mice were placed in a water-cooled four-turn helical induction coil. Two additional mice, used as controls, were placed in the coil but received no AMF exposure. Tissue and core temperatures as the response were measured in situ and recorded at 1-second intervals.

Results: No adverse effects were observed for AMF amplitudes of 700 Oe, even at continuous power application (100% duty) for up to 20 minutes. Mice exposed to AMF amplitudes in excess of 950 Oe experienced morbidity and injury when the duty exceeded 50%.

Conclusion: High-amplitude AMF (up to 1,300 Oe) was well tolerated provided the duty was adjusted to dissipate heat. Results presented suggest that further tissue temperature regulation can be achieved with suitable variations of pulse width for a given amplitude and duty combination. These results suggest that it is possible to apply high-amplitude AMF (>500 Oe) with pulsing for a time sufficient to treat cancer tissue in which magnetic nanoparticles have been embedded.

This article has been cited by other articles:

				S. J. DeNardo, G. L. DeNardo, A. Natarajan, L. A. Miers, A. R. Foreman, C. Gruettner, G. N. Adamson, and R. Ivkov Thermal Dosimetry Predictive of Efficacy of 111In-ChL6 Nanoparticle AMF-Induced Thermoablative Therapy for Human Breast Cancer in Mice J. Nucl. Med., March 1, 2007; 48(3): 437 - 444. [Abstract] [Full Text] [PDF]

				S. J. DeNardo, G. L. DeNardo, L. A. Miers, A. Natarajan, A. R. Foreman, C. Gruettner, G. N. Adamson, and R. Ivkov Development of Tumor Targeting Bioprobes (111In-Chimeric L6 Monoclonal Antibody Nanoparticles) for Alternating Magnetic Field Cancer Therapy Clin. Cancer Res., October 1, 2005; 11(19): 7087s - 7092s. [Abstract] [Full Text] [PDF]